$EQBK

StoneX raises Equity Bancshares stock price target to $59 on acquisition

StoneX raised its price target for Equity Bancshares (EQBK) to $59 from $57, citing the company's acquisition of Lincoln Bancorp. EQBK shares are near their 52-week high, up 15% year-to-date. StoneX also increased its earnings estimates for EQBK, aligning with broader analyst optimism. The stock is currently trading at $51.50.

Original reporting
Published Sep 4, 2026, 3:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 4, 2026, 3:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$EQBK
Bullish
medium confidence
Mentioned
$EQBK
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$EQBKBullishMed
01

Why it matters

Higher price target and acquisition signal potential upside, but revenue weakness remains a risk.

02

Market read

The deal and upgraded target could drive EQBK stock higher, influencing community bank sector sentiment.

03

What to watch

Revenue miss in Q2 could temper enthusiasm despite earnings beat.

Relevance 7/10Novelty 7/10Timing: today

Background

Equity Bancshares reported Q2 earnings beat but revenue miss; analysts are adjusting targets.

Company-level read

Ticker impact

$EQBKBullishMedium confidence
Context

StoneX raised its price target to $59 and noted EQBK's acquisition of Lincoln Bancorp for $124 million.

Expected impact

Potential short‑term rally toward $59 target.

Evidence & confidence

Deal adds cash assets and synergies; analysts are raising earnings estimates.

Market effects

Regional banking consolidation may lift peer valuations.

U.S. community banks could see modest buying pressure.

Limited to U.S. banking sector.

Counterpoint

Acquisition cost may strain balance sheet if synergies fall short.

Key entities

  • Equity Bancshares Inc.

    U.S. regional bank (ticker EQBK).

  • Lincoln Bancorp

    Target of EQBK's $124 million acquisition.

Related articles

$EQBKMed

Equity Bancshares (EQBK) Q3 2026 Earnings Call Transcript

Equity Bancshares (EQBK) reported Q3 2026 earnings, highlighting organic growth with loans up $39M to $5.44B and deposits down $136M to $6.17B. The company announced a merger with Lincoln Bancorp, adding 16 branches in Iowa. Net income was $26.8M, or $1.29 per diluted share. The company expects margin to return to 4.25-4.35% in Q4, excluding the merger.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.

$EQBKMed

Equity Bancshares Q3 2026 slides: EPS beats amid margin pressure

Equity Bancshares (EQBK) reported Q3 2026 earnings of $1.40 per share, beating estimates, though revenue fell slightly short. The stock rose 0.99% to $47.03. The bank faces margin pressure but continues growth through acquisitions, including the pending Lincoln Savings Bank deal. Asset quality showed some deterioration, with nonperforming assets rising to 0.99%. The company is investing in AI to improve efficiency.

$EQBKMed

Equity Bancshares (EQBK) Posts Solid Net Interest Income Despite

Equity Bancshares (EQBK) reported Q2 2026 net interest income of $72.8M, down slightly from the prior quarter but up 16.6% year-over-year. The company's GF Value™ suggests it is modestly undervalued with a 15.2% margin of safety. EQBK has a GF Score™ of 81/100, indicating strong fundamentals in valuation and momentum, but weaker financial strength. Insiders and gurus have shown net selling activity. The stock trades at $46.57 with a trailing P/E of 27.97x and a forward P/E of 8.55x.